Quantitation of minimal residual disease in multiple myeloma using an allele-specific real-time PCR assay-Reference-Cited by-同舟云学术

Quantitation of minimal residual disease in multiple myeloma using an allele-specific real-time PCR assay

Published:2000-09 Issue:9 Volume:28 Page:1039-1045
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Rasmussen Thomas,Poulsen Tim Svenstrup,Honoré Lone,Johnsen Hans Erik

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference24 articles.

1. Immunoglobulin gene ‘fingerprinting’;Deane;Br J Haematol,1991

2. Corradini P, Voena C, Omede P, et al. (1993) Detection of circulating tumor cells in multiple myeloma by a PCR-based method. Leukemia 7:1879

3. Detection of clonal immunoglobulin gene rearrangements in the PBPC harvests of patients with acute lymphoblastic leukaemia;Owen;Bone Marrow Trans,1995

4. Identification of malignant cells in multiple myeloma bone marrow with immunoglobulin VH gene probes by fluorescent in situ hybridization and flow cytometry;Cao;J of Clin Invest,1995

5. Sequential analysis of bone marrow and peripheral blood after stem cell transplant for myeloma shows disparate tumor involvement;Billadeau;Leukemia,1997

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcription factor-driven coordination of cell cycle exit and lineage-specification in vivo during granulocytic differentiation;Nature Communications;2022-06-23

2. Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis;International Journal of Molecular Sciences;2021-07-13

3. Ficolled bone marrow is superior to bone marrow buffy coat for detection of minimal residual disease in multiple myeloma;Hematology;2019-01-01

4. Molecular detection of minimal residual disease in multiple myeloma;British Journal of Haematology;2017-12-19

5. Diagnosis of Plasma Cell Dyscrasias and Monitoring of Minimal Residual Disease by Multiparametric Flow Cytometry;Clinics in Laboratory Medicine;2017-12